$CTIX Recent Headlines Cellceutix Overvalued By 90-99%

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Infosys: Fastest Growing IT Services Brand Infosys, a standout leader in the realm of digital services, has recently been hailed as the fastest-growing IT services brand. Their extraordinary annual growth rate of 15% in brand value is a testament to their robust market strategies and trusted services. Recognition by Brand Finance The prestigious brand valuation firm Brand...

Sarclisa Gains FDA Approval: A New Hope Recently, Sarclisa, developed by Sanofi’s SA (NASDAQ: SNY), received pivotal FDA approval as a first-line treatment for adult patients with newly diagnosed multiple myeloma (NDMM) who are unable to undergo autologous stem cell transplantation (ASCT). This approval represents a significant breakthrough for those grappling with this...

Understanding Rayonier's 2024 Dividend Tax Treatment Rayonier Inc. (NYSE: RYN), a prominent timberland real estate investment trust, has recently announced the tax implications associated with its 2024 dividend distributions on common stock. As a shareholder, grasping the tax treatment of these dividends is essential for effective financial planning. Dividend Overview and...

Delta Airlines Expects a Resilient Year-End Performance Delta Airlines Inc (NYSE: DAL) is navigating a challenging landscape yet remains optimistic about closing the year on a positive note. Following a significant technology failure this summer that impacted operations, the airline is poised to leverage the holiday travel surge to bolster its earnings. Impact of...

Cyngn Aims for Growth with New Funding Cyngn enters the new year with enthusiasm and significant momentum, fueled by its recent funding of $33 million aimed at enhancing production and deployment of its autonomous industrial vehicles. The focus is particularly on the DriveMod Tuggers and the highly anticipated DriveMod Forklifts, showcasing the company's commitment to...